October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Rahul Gosain: FDA approval of Fruquintinib from FRESCO2 and how it fits in our Rx paradigm with N. Arvind Dasari
Apr 29, 2024, 07:58

Rahul Gosain: FDA approval of Fruquintinib from FRESCO2 and how it fits in our Rx paradigm with N. Arvind Dasari

Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, recently shared on LinkedIn:

GISeries: In this episode, we get a chance to discuss FDA approval of Fruquintinib from FRESCO2 and how it fits in our treatment paradigm with N. Arvind Dasari.

Full Interview:
– On Targeted Oncology,
– On OncBrothers,
– Also on the ‘Oncology Brothers’ podcast.”

View the attached video.
Source: Rahul Gosain/LinkedIn